カルシウムアンタゴニストは安全ですか?

Same author

Urocortin 2 - a protective effect in hypertension?

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023

Same author

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

International journal of cardiology·2021

Same author

More SPRINT controversy.

Journal of internal medicine·2017

Same author

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Hipertension y riesgo vascular·2015

Same author

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Journal of internal medicine·2009

Same author

Beta-blockers as fourth-line therapy for hypertension: stay the course.

International journal of clinical practice·2009

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

カルシウムアンタゴニストは安全ですか?

関連する概念動画

Urocortin 2 - a protective effect in hypertension?

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

More SPRINT controversy.

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Beta-blockers as fourth-line therapy for hypertension: stay the course.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

カルシウムアンタゴニストは安全ですか?

関連する概念動画

関連記事

Urocortin 2 - a protective effect in hypertension?

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

More SPRINT controversy.

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Beta-blockers as fourth-line therapy for hypertension: stay the course.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.